An interventional study of Physiotherapy in Breast, Posture and Mammaplasty, sponsored by Istanbul Rumeli University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-07-27.
Sponsored by Istanbul Rumeli University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 393 studies in Sleep Initiation and Maintenance Disorders with a site in Turkey — 98 open to participants now, 111 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Turkey.
Among the 393 studies in Sleep Initiation and Maintenance Disorders with a site in Turkey, this one is the 250th largest by planned enrollment of the 311 interventional ones that give a count, is one of 68 that started in 2026, is one of 309 with no phase, reaches primary completion later than 62 of the 110 other live ones, and was the 329th registered.
2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.
Browse Sleep Initiation and Maintenance Disorders studies →98 of the 393 studies in Sleep Initiation and Maintenance Disorders with a site in Turkey are open now. Recruiting first, the newest first:
Mersin University · Sites in Turkey
Ages 18+
Dokuz Eylul University · Sites in Turkey
Ages 18+
Gazi University · Sites in Turkey
Ages 50–60 · Women only
Medipol University · Sites in Turkey
Ages 18–65 · Healthy volunteers
Konya Beyhekim Training and Research Hospital · Sites in Turkey
Ages 40–55 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.
This study: 18 Years to 50 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
393 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 68 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 68 across 2,363 interventional studies indexed under Sleep Initiation and Maintenance Disorders.
Median enrollment 60 across the 311 interventional studies, 120 across the 82 observational. Of the 263 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 393 have an industry lead sponsor. The 10 most frequent:
Istanbul Rumeli University is the lead sponsor of 26 studies on the registry; 11 are open to participants now.
Istanbul Rumeli University has 1 study filed under Sleep Initiation and Maintenance Disorders — fewer than ten, so there is no comparison to draw.
35 of the studies in Sleep Initiation and Maintenance Disorders with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07503080Filiz KeskinVirtual Reality (VR) Based Relaxation for Nausea and Comfort in Pregnancy | 2026-11 |
| NCT07933263Inonu UniversityThe Effect of Post-Caesarean Section Transcutaneous Electrical Nerve Stimulation(Tens) Treatment on the Severity of Pain, Mobility and Insomnia: A Randomised Controlled Trial | 2026-12 |
| NCT07499245Kafkas UniversityThe Effect of Virtual Reality in Older Adults | 2026-12 |
| NCT07832721Volkan GokmenSleep, Mindfulness, and Shift-Level Safety Performance in Perianesthesia Nurses | 2026-12 |
| NCT07718399Halic UniversitySpirulina Supplementation in Postmenopausal Women | 2026-12 |
Add all 35 to your calendar (.ics) → With an account.
Among the 393 studies in Sleep Initiation and Maintenance Disorders with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Background and Purpose:
Breast reduction surgery is a major procedure that can lead to post-operative pain, postural deviations, and a temporary decline in quality of life.This clinical study aims to investigate the efficacy of early-phase physical therapy on pain management, postural alignment, and overall quality of life in female patients following breast reduction surgery.
Study Design and Participants:
This is a controlled clinical trial involving 40 female participants aged 18 to 50 who have undergone their first breast reduction surgery. Participants are divided into two groups: an intervention group (n=20) and a control group (n=20). The study follows a pre-test and post-test design to evaluate outcomes before and after a three-week intervention period.
Intervention Protocol:
The intervention group receives a comprehensive physical therapy program starting one week post-operation. The program is conducted three days a week for three weeks, with sessions lasting 40 to 60 minutes The protocol includes:
Postural and cervical exercises Scapular stabilization and manual therapy Scar massage and Transcutaneous Electrical Nerve Stimulation (TENS) as needed A structured home exercise program.
Outcome Measures:
Primary and secondary outcomes are assessed through various clinical tools:
Pain:Visual Analog Scale (VAS) Posture: New York Posture Test, measurements of scapular protraction and cervical anterior tilt Mobility:Shoulder and cervical Range of Motion (ROM) Quality of Life and Health: SF-12, BREAST-Q, and Pittsburgh Sleep Quality Index (PSQI)
Expected Results:
The study anticipates that the early-phase physical therapy group will demonstrate a significant reduction in pain, improved postural alignment, and a higher quality of life compared to the control group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Oncological History:
Those who have been diagnosed with breast cancer in the pre-operative or per-operative period, or those with a history of radiotherapy/chemotherapy to the breast area,
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Exercise programme
Other: Physiotherapy
No intervention.
The participants will attend a physiotherapy programme. The programme includes some exercises.
Breast-Q Reduction Module Score
Breast-related satisfaction will be assessed using the BREAST-Q Reduction Module.
Time frame: Baseline (preoperative) and 4 weeks after treatment
Posture Evaluation
New York Posture Rating Test score will be assessed.
Time frame: Baseline and 4 weeks after treatment
Pain Intensity (VAS)
Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS). The scale ranges from 0 (no pain) to 10 (unbearable pain). Participants will mark their pain level on the scale, and the distance in centimeters will be recorded.
Time frame: Baseline (preoperative) and 4 weeks after treatment
Quality of Life (SF-12)
Health-related quality of life will be assessed using the SF-12 questionnaire.
Time frame: Baseline and 4 weeks after treatment
Pittsburgh Sleep Quality Index Total Score
Total PSQI score will be assessed.
Time frame: Baseline and 4 weeks after treatment
PDFs hosted by the registry, ClinicalTrials.gov.
Start is estimated for Jul 2026; primary completion for Aug 2026, 0 months later.
Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 0 months is below that.
Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleep Initiation and Maintenance Disorders →
Istanbul Rumeli University